Effectiveness of the pharmacist-involved multidisciplinary management of heart failure to improve hospitalizations and mortality rates in 4630 patients: a systematic review and meta-analysis of randomized controlled trials.

[1]  S. Anker,et al.  Pharmacy‐based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM‐CHF randomized controlled trial , 2019, European journal of heart failure.

[2]  I. Piña,et al.  Heart Failure Postdischarge Clinic: A Pharmacist-led Approach to Reduce Readmissions. , 2019, Current problems in cardiology.

[3]  Sanjiv J. Shah,et al.  Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Trials. , 2018, JACC. Heart failure.

[4]  M. Moulton,et al.  Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction , 2018, Expert review of cardiovascular therapy.

[5]  Y. Kato,et al.  Pharmacist-led intervention in the multidisciplinary team approach optimizes heart failure medication , 2018, Heart and Vessels.

[6]  S. Kenchaiah,et al.  The Current Focus of Heart Failure Clinical Trials. , 2018, Journal of cardiac failure.

[7]  Judy W. M. Cheng.  Current perspectives on the role of the pharmacist in heart failure management , 2018, Integrated pharmacy research & practice.

[8]  Shubha Bhat,et al.  Outcomes of a Pharmacist-Managed Heart Failure Medication Titration Assistance Clinic , 2018, The Annals of pharmacotherapy.

[9]  Pamela M. Moye,et al.  Impact of a pharmacy team–led intervention program on the readmission rate of elderly patients with heart failure , 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[10]  C. Yancy,et al.  Pharmacist Education at Discharge Correlates with Reduced 30-Day Readmissions in Heart Failure Patients , 2017 .

[11]  M. Khan,et al.  Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis , 2017, Circulation. Heart failure.

[12]  S. Solomon,et al.  Declining Risk of Sudden Death in Heart Failure , 2017, The New England journal of medicine.

[13]  Shannon M. Dunlay,et al.  Epidemiology of heart failure with preserved ejection fraction , 2017, Nature Reviews Cardiology.

[14]  S. Hummel,et al.  Impact of a Pharmacist-Managed Heart Failure Postdischarge (Bridge) Clinic for Veterans , 2017, The Annals of pharmacotherapy.

[15]  R. Clark,et al.  Role of the Pharmacist for Improving Self-care and Outcomes in Heart Failure , 2017, Current Heart Failure Reports.

[16]  J. McMurray,et al.  Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction , 2017, Circulation. Heart failure.

[17]  K. Ryu,et al.  Temporal Trends of Hospitalized Patients with Heart Failure in Korea , 2016, Korean circulation journal.

[18]  M. Packer.  Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective , 2016, Circulation.

[19]  M. Redfield.  Heart Failure with Preserved Ejection Fraction. , 2016, The New England journal of medicine.

[20]  R. Mitchell,et al.  Heart failure therapies: new strategies for old treatments and new treatments for old strategies. , 2016, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[21]  P. Ponikowski,et al.  2016 ESC and ACC/AHA/HFSA heart failure guideline update — what is new and why is it important? , 2016, Nature Reviews Cardiology.

[22]  C. Chew‐Graham,et al.  The implications of living with heart failure; the impact on everyday life, family support, co-morbidities and access to healthcare: a secondary qualitative analysis , 2016, BMC Family Practice.

[23]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[24]  Ajinkya C. Inamdar,et al.  Heart Failure: Diagnosis, Management and Utilization , 2016, Journal of clinical medicine.

[25]  G. Fonarow,et al.  Epidemiology and aetiology of heart failure , 2016, Nature Reviews Cardiology.

[26]  M. Frenneaux,et al.  Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm , 2016, British journal of pharmacology.

[27]  Jeroen J. Bax,et al.  Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency , 2016, European journal of heart failure.

[28]  R. Arora,et al.  Effective Strategies in Reducing Rehospitalizations in Patients With Heart Failure , 2016, American journal of therapeutics.

[29]  D. Kotecha,et al.  Comorbidities in Heart Failure: Are There Gender Differences? , 2016, Current Heart Failure Reports.

[30]  M. Horvat,et al.  Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: A randomized, double-blind, controlled trial. , 2016, International journal of cardiology.

[31]  M. Jessup,et al.  Understanding Heart Failure. , 2015, Cardiac electrophysiology clinics.

[32]  D. Mancini,et al.  Management of Noncardiac Comorbidities in Chronic Heart Failure. , 2015, Cardiovascular therapeutics.

[33]  P. Sedgwick,et al.  How to read a funnel plot in a meta-analysis , 2015, BMJ : British Medical Journal.

[34]  C. Tufanaru,et al.  Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness , 2015, International journal of evidence-based healthcare.

[35]  N. Azad,et al.  Management of chronic heart failure in the older population , 2014, Journal of geriatric cardiology : JGC.

[36]  D. Altman,et al.  Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews , 2014, BMJ : British Medical Journal.

[37]  S. Sugihara,et al.  Multidisciplinary intensive education in the hospital improves outcomes for hospitalized heart failure patients in a Japanese rural setting , 2014, BMC Health Services Research.

[38]  C. Jackevicius,et al.  The Pharmacist Role in Predicting and Improving Medication Adherence in Heart Failure Patients , 2014, Journal of managed care & specialty pharmacy.

[39]  D. Kass,et al.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. , 2014, Circulation research.

[40]  Talicia A Tarver.  HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .

[41]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[42]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[43]  L. Goldraich,et al.  Cost-effectiveness of heart failure therapies , 2013, Nature Reviews Cardiology.

[44]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[45]  G. Ogedegbe,et al.  Heart failure–associated hospitalizations in the United States. , 2013, Journal of the American College of Cardiology.

[46]  Robert O. Bonow,et al.  Rehospitalization for heart failure: problems and perspectives. , 2013, Journal of the American College of Cardiology.

[47]  Leora I. Horwitz,et al.  Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. , 2013, JAMA.

[48]  P. Barlis,et al.  Pharmacist directed home medication reviews in patients with chronic heart failure: a randomised clinical trial. , 2012, International journal of cardiology.

[49]  Akshay S. Desai,et al.  Rehospitalization for heart failure: predict or prevent? , 2012, Circulation.

[50]  P. Austin,et al.  Lifetime Analysis of Hospitalizations and Survival of Patients Newly Admitted With Heart Failure , 2012, Circulation. Heart failure.

[51]  J. McMurray,et al.  Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. , 2012, European heart journal.

[52]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[53]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[54]  D. J. Veldhuisen,et al.  Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction , 2011, European journal of heart failure.

[55]  P. Bergin,et al.  Impact of a Pharmacist Intervention on Ambulatory Patients with Heart Failure: A Randomised Controlled Study , 2011 .

[56]  Angelo Auricchio,et al.  What are the costs of heart failure? , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[57]  G. Guyatt,et al.  GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). , 2011, Journal of clinical epidemiology.

[58]  V. Roger,et al.  Lifetime Costs of Medical Care After Heart Failure Diagnosis , 2011, Circulation. Cardiovascular quality and outcomes.

[59]  A. Jha,et al.  Who Has Higher Readmission Rates for Heart Failure, and Why?: Implications for Efforts to Improve Care Using Financial Incentives , 2011, Circulation. Cardiovascular quality and outcomes.

[60]  A. Lenderink,et al.  The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure , 2010, Pharmacy World & Science.

[61]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[62]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[63]  S. Normand,et al.  Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission , 2009, Circulation. Cardiovascular quality and outcomes.

[64]  A. Strömberg,et al.  The European Heart Failure Self‐care Behaviour scale revised into a nine‐item scale (EHFScB‐9): a reliable and valid international instrument , 2009, European journal of heart failure.

[65]  K. Schulman,et al.  Early and long-term outcomes of heart failure in elderly persons, 2001-2005. , 2008, Archives of internal medicine.

[66]  R. Perera,et al.  Interpreting meta-analysis in systematic reviews , 2008, Annals of Internal Medicine.

[67]  F. Molnar,et al.  Lessons learned from a multidisciplinary heart failure clinic for older women: a randomised controlled trial. , 2008, Age and ageing.

[68]  F. McAlister,et al.  Pharmacist care of patients with heart failure: a systematic review of randomized trials. , 2008, Archives of internal medicine.

[69]  R. Hamilton,et al.  Effect of pharmaceutical care services on outcomes for home care patients with heart failure. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[70]  Wanzhu Tu,et al.  Pharmacist Intervention to Improve Medication Adherence in Heart Failure , 2007, Annals of Internal Medicine.

[71]  L. Shepstone,et al.  Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial , 2007, BMJ : British Medical Journal.

[72]  Karin Ried,et al.  Interpreting and understanding meta-analysis graphs--a practical guide. , 2006, Australian family physician.

[73]  Gordon Guyatt,et al.  Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. , 2005, American heart journal.

[74]  J. McElnay,et al.  Pharmaceutical care of patients with heart failure. , 2005, British journal of clinical pharmacology.

[75]  Jeffrey A. Johnson,et al.  A multicenter disease management program for hospitalized patients with heart failure. , 2004, Journal of cardiac failure.

[76]  A. Hoes,et al.  Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. , 2003, Journal of cardiac failure.

[77]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[78]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[79]  V. Hasselblad,et al.  Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. , 1999, Archives of internal medicine.

[80]  J. McElnay,et al.  Pharmaceutical Care of Patients with Congestive Heart Failure: Interventions and Outcomes , 1999, Pharmacotherapy.

[81]  E. Rainville.  Impact of pharmacist interventions on hospital readmissions for heart failure. , 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[82]  S. Stewart,et al.  Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. , 1998, Archives of internal medicine.

[83]  P. Milligan,et al.  DOES ENCOURAGING GOOD COMPLIANCE IMPROVE PATIENTS' CLINICAL CONDITION IN HEART FAILURE? , 1995, The British journal of clinical practice.

[84]  L. Gardner,et al.  Interprofessional care collaboration for patients with heart failure. , 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[85]  C. Farquhar,et al.  There were large discrepancies in risk of bias tool judgments when a randomized controlled trial appeared in more than one systematic review. , 2017, Journal of clinical epidemiology.

[86]  Javed Butler,et al.  Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions. , 2011, Journal of cardiac failure.

[87]  Cochrane Handbook for Systematic Reviews of Interventions Edited by Julian P. T. Higgins & , 2006 .

[88]  C. Cabezas,et al.  Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure. , 2006 .

[89]  S. Stewart,et al.  Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006. , 2006 .

[90]  C. López Cabezas,et al.  Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure. , 2006, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.